quinolinic acid has been researched along with rolipram in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Block, F; Nolden-Koch, M; Schmidt, W; Schwarz, M | 1 |
| Block, F; Frohn, C; Loos, M; Schwarz, M | 1 |
| Bernardi, G; DeMarch, Z; Fusco, FR; Giampà, C; Martorana, A; Patassini, S | 1 |
4 other study(ies) available for quinolinic acid and rolipram
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Rolipram reduces excitotoxic neuronal damage.
Topics: Animals; Antidepressive Agents; Cell Count; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Immunohistochemistry; Male; Neostriatum; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Quinolinic Acid; Rats; Rats, Wistar; Rolipram; Tumor Necrosis Factor-alpha | 2001 |
Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion.
Topics: Animals; Brain Diseases; Cell Count; Chondroitin Sulfate Proteoglycans; Corpus Striatum; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Functional Laterality; Glial Fibrillary Acidic Protein; Immunohistochemistry; Inflammation; Keratan Sulfate; Lumican; Male; Phosphodiesterase Inhibitors; Phosphopyruvate Hydratase; Quinolinic Acid; Rats; Rats, Wistar; Rolipram; Substantia Nigra; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity.
Topics: Animals; Cell Survival; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Huntington Disease; Immunohistochemistry; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Phosphodiesterase Inhibitors; Phosphorylation; Quinolinic Acid; Rats; Rats, Wistar; Rolipram; Treatment Outcome; Up-Regulation | 2007 |